Friday, January 27, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Antimicrobial Resistance

PHEMCE Medical Countermeasure Stakeholders Workshop

by Global Biodefense Staff
November 19, 2015
PHEMC Medical Countermeasures Workshop

U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response will host a Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Stakeholder’s Workshop Jan. 6-7, 2016, in Bethesda, Maryland.

This two-day workshop will highlight past progress and future directions in developing, stockpiling and effectively utilizing the drugs, vaccines, and devices that may be required in public health emergencies caused by either naturally occurring epidemics or intentional chemical, biological, radiological and nuclear (CBRN) attacks.

The workshop will feature a mix of plenary sessions and in-depth breakout sessions along four tracks, addressing topics which include:

  • Clinical Guidance on the Use of Medical Countermeasures
  • Biosafety and Biosecurity
  • Post-Marketing Data On Safety and Efficacy for MCMs Approved Under Animal Rule
  • The Strategic National Stockpile
  • Science Needs During Crisis Response
  • Focusing On Populations with Special Needs
  • Influenza and Respiratory Pathogens Update
  • NIH Support and Services for Medical Countermeasure Development
  • Combating Antibiotic Resistant Bacteria Program
  • Past, Present and Future of the MCM Initiative at FDA
  • The MERS CoV Connection
  • Ebola Response – After Action Report

Advance registration is required for the PHEMCE Stakeholders Workshop. Registration will close on December 11, 2015 or when the event reaches capacity.

Source: PHE.gov, adapted.

Tags: AntimicrobialsAntitoxinsAntiviralsBiosafetyEbolaEmerging ThreatsInfluenzaMERS-CoVPandemicVaccines

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
How Are Bivalent COVID Vaccines Stacking Up Against Omicron?
Infectious Diseases

How Are Bivalent COVID Vaccines Stacking Up Against Omicron?

January 12, 2023
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC